To evaluate whether similar changes in muscle weight occur in EAE and MS in humans, we determined in this study the muscle weight and gene expression of myosin heavy chains (MyHC) and OXPHOS components ex vivo (post-mortem). The gene discussed is MYH6; the disease is myeloid sarcoma.